UnitedHealth Group Incorporated (NYSE:UNH) was downgraded by investment analysts at BidaskClub from a “strong-buy” rating to a “buy” rating in a report released on Wednesday, July 19th.
A number of other research firms also recently commented on UNH. Sanford C. Bernstein restated an “outperform” rating and issued a $190.00 price objective on shares of UnitedHealth Group in a report on Monday, July 10th. Cantor Fitzgerald restated a “buy” rating and issued a $205.00 price objective on shares of UnitedHealth Group in a report on Friday, July 7th. Bank of America Corporation raised their price objective on UnitedHealth Group from $210.00 to $214.00 and gave the stock a “buy” rating in a report on Friday, July 14th. Cowen and Company restated a “buy” rating on shares of UnitedHealth Group in a report on Friday, July 14th. Finally, Credit Suisse Group restated an “outperform” rating and issued a $200.00 price objective (up from $195.00) on shares of UnitedHealth Group in a report on Thursday, July 13th. One investment analyst has rated the stock with a hold rating and twenty-four have issued a buy rating to the stock. The company presently has an average rating of “Buy” and a consensus price target of $202.20.
UnitedHealth Group (NYSE:UNH) traded up 0.23% during trading on Wednesday, hitting $193.02. 2,210,720 shares of the company were exchanged. The firm’s 50 day moving average price is $189.36 and its 200-day moving average price is $174.75. The stock has a market capitalization of $186.62 billion, a PE ratio of 23.19 and a beta of 0.64. UnitedHealth Group has a 1-year low of $132.39 and a 1-year high of $196.04.
UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, July 18th. The healthcare conglomerate reported $2.46 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $2.38 by $0.08. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.32%. The firm had revenue of $50.05 billion for the quarter, compared to the consensus estimate of $49.97 billion. During the same period in the prior year, the business posted $1.96 earnings per share. The firm’s revenue for the quarter was up 7.7% compared to the same quarter last year. Equities analysts predict that UnitedHealth Group will post $9.87 EPS for the current year.
TRADEMARK VIOLATION WARNING: This story was originally posted by BNB Daily and is the sole property of of BNB Daily. If you are accessing this story on another website, it was illegally copied and reposted in violation of U.S. & international copyright & trademark legislation. The correct version of this story can be viewed at https://www.baseball-news-blog.com/2017/08/13/unitedhealth-group-incorporated-unh-lowered-to-buy-at-bidaskclub-updated-updated-updated.html.
In other UnitedHealth Group news, Director William C. Ballard, Jr. sold 5,000 shares of UnitedHealth Group stock in a transaction on Thursday, August 3rd. The stock was sold at an average price of $193.98, for a total transaction of $969,900.00. Following the sale, the director now owns 76,058 shares of the company’s stock, valued at approximately $14,753,730.84. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Gail R. Wilensky sold 5,540 shares of UnitedHealth Group stock in a transaction on Friday, June 2nd. The shares were sold at an average price of $178.74, for a total value of $990,219.60. Following the sale, the director now directly owns 60,516 shares in the company, valued at approximately $10,816,629.84. The disclosure for this sale can be found here. In the last three months, insiders sold 15,540 shares of company stock worth $2,873,320. Company insiders own 0.89% of the company’s stock.
Institutional investors have recently modified their holdings of the stock. Patriot Financial Group Insurance Agency LLC boosted its position in shares of UnitedHealth Group by 1,722.9% in the first quarter. Patriot Financial Group Insurance Agency LLC now owns 638 shares of the healthcare conglomerate’s stock valued at $106,000 after buying an additional 603 shares during the period. Blue Chip Partners Inc. purchased a new position in shares of UnitedHealth Group during the second quarter valued at about $110,000. Intellectus Partners LLC purchased a new position in shares of UnitedHealth Group during the fourth quarter valued at about $111,000. Thomas J. Herzfeld Advisors Inc. purchased a new position in shares of UnitedHealth Group during the fourth quarter valued at about $111,000. Finally, Cribstone Capital Management LLC boosted its position in shares of UnitedHealth Group by 22.6% in the first quarter. Cribstone Capital Management LLC now owns 678 shares of the healthcare conglomerate’s stock valued at $113,000 after buying an additional 125 shares during the period. Institutional investors own 86.37% of the company’s stock.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Incorporated Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com’s FREE daily email newsletter.